- Head and neck cancer
- Lung cancer
Aditi P. Singh, MD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Penn Medicine Provider
About me
- Associate Professor of Clinical Medicine (Hematology-Oncology)
My education and training
- Medical School: Lady Hardinge Medical College
- Residency: University of Alabama Medical Center
- Residency: Tufts - New England Medical Center
- Fellowship: Montefiore Medical Center
Spoken languages
English
English
ਪੰਜਾਬੀ
Punjabi
हिन्दी
Hindi
Reviews
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Singh is a Penn Medicine physician.
Qualifications and experience
- Hematology, 2018
- Medical Oncology, 2018
- American Medical Association, National
- American Society of Clinical Oncology, National
- International Association for the Study of Lung Cancer, International
- National Comprehensive Cancer Network (NCCN), National
- North American Neuroendocrine Tumor Society, International
- Penn Center for Head and Neck Cancer
- Penn Lung Cancer Program
- Penn Mesothelioma Program
- Penn Neuroendocrine Tumor Program
- Penn Pleural Disease Program
Treatments and conditions
Research
Publications
Aditi P Singh, Abigail T Berman, Melina E Marmarelis, Andrew R Haas, Steven J Feigenberg, Jennifer Braun, Christine A Ciunci, Joshua M Bauml, Roger B Cohen, John C Kucharczuk, Lawrence N Shulman, Corey J Langer, Charu Aggarwal Management of Lung Cancer During the COVID-19 Pandemic , JCO Oncol Pract, 16(9): 2020,579-586
Charu Aggarwal, Jeffrey C. Thompson, Austin L. Chien, Katie J. Quinn, Wei-Ting Hwang, Taylor A. Black, Stephanie S. Yee, Theresa E. Christensen, Michael J. LaRiviere, Benjamin A. Silva, Kimberly C. Banks, Rebecca J. Nagy, Elena Helman, Abigail T. Berman, Christine A. Ciunci, Aditi P. Singh, Jeffrey S. Wasser, Joshua M. Bauml, Corey J. Langer, Roger B. Cohen and Erica L. Carpenter Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer , Clin Cancer Res , 26(10): 2020,2354-2361
Aditi P. Singh, Elaine Shum, Lakshmi Rajdev, Haiying Cheng, Sanjay Goel, Roman Perez-Soler, Balazs Halmos Impact and diagnostic gaps of comprehensive genomic profiling in real-world clinical practice , Cancers, 12(5): 2020,1156
Qinfang Deng, Qiyu Fang, Hui Sun Aditi P. Singh, Mariam Alexander, Shenduo Li, Haiying Cheng, Songwen Zhou. Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis , Cancer Med, 9(6): 2020,2085-2095
Attarian S, Guo X, Ko B, Singh AP, Castellucci E, Gucalp R, Haigentz M, Cheng H, Halmos B. Lung cancer in patients with HIV - Unique features impacting lung cancer screening and management , World Lung Cancer Conference - Virtual Meeting: 2019
Singh AP, Alexander M, Goradia N, Cheng H Practical Advice for Treating Leptomeningeal Disease in Non–Small Cell Lung Cancer , The Journal of Targeted Therapies in Cancer, 26(9): 2018
Singh AP, Cheng H, Guo X, Levy B, Halmos B. Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician , Journal of Clinical Oncology/Precision Oncology : 2017
Singh AP, Li S, Cheng H. Circulating DNA in EGFR-mutated lung cancer. , Ann Transl Med, 5(18): 2017,379
Hardin C, Shum E, Singh AP, Perez-Soler R, Cheng H. Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer. , Expert Opin Pharmacother, 18(7): 2017,701-716
Puri Singh A, Haywood C Jr, Beach MC, Guidera M, Lanzkron S, Valenzuela-Araujo D, Rothman RE, Dugas AF. Improving Emergency Providers' Attitudes Toward Sickle Cell Patients in Pain. , J Pain Symptom Manage, 51(3): 2016,628-32